Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

4.0%

2 terminated out of 50 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

42%

10 of 24 completed with results

Key Signals

10 with results92% success

Data Visualizations

Phase Distribution

44Total
Not Applicable (32)
Early P 1 (1)
P 1 (5)
P 2 (3)
P 4 (3)

Trial Status

Completed24
Recruiting10
Unknown7
Terminated2
Not Yet Recruiting2
Withdrawn2

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT06462196Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

NCT06139159Not ApplicableActive Not RecruitingPrimary

CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos

NCT07051148Not ApplicableNot Yet Recruiting

Efficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Trial

NCT06973759Not ApplicableRecruitingPrimary

Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness

NCT05991232Phase 1WithdrawnPrimary

Repeated Neurocognitive Measurements in Depressed Patients

NCT04121091Phase 2Completed

Pramipexole to Target "Anhedonic Depression"

NCT03466346Not ApplicableCompletedPrimary

SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project

NCT07007247Not ApplicableEnrolling By Invitation

Development and Evaluation of a Digital Aftercare Program for Adolescents (12-17 Years) With Depressive Symptoms After Hospital Discharge (Mind-WIN Pilot Study) (Mind-WIN Pilot)

NCT06590038Not ApplicableCompletedPrimary

Psychotherapy Feasibility Pilot of the Carolina Recovery From Depression Protocol

NCT04640636Phase 4SuspendedPrimary

IM Ketamine vs Midazolam for Suicidal ER Patients

NCT05640089Not ApplicableRecruitingPrimary

FMRI-neurofeedback in Depression

NCT06392867Not ApplicableRecruitingPrimary

Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study

NCT05146427Not ApplicableWithdrawn

Pilot Study: Investigating Mood Changes After Slow-wave Enhancement

NCT05958940Not ApplicableRecruitingPrimary

BioClock: Bright Light Therapy for Depressive Disorders

NCT03096886Not ApplicableCompleted

Novel Neural Circuit Biomarkers of Major Depression Response to CCBT

NCT04916548Phase 1CompletedPrimary

Repeated Neurocognitive Measurements in Depressed Patients

NCT05168735Phase 1CompletedPrimary

Ketamine + Mindfulness for Depression

NCT06534684Not ApplicableRecruitingPrimary

The Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression

NCT06094907Phase 2Completed

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

NCT05767073Not ApplicableRecruiting

LIVES: Personalized Lifestyle Intervention for Patients With Depression

Scroll to load more

Research Network

Activity Timeline